Podnos Yale: insider trades.
Podnos Yale reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($150K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Podnos Yale
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Oncology Institute, Inc. (STLN) | Officer · Chief Medical Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-14 | Oncology Institute, Inc. | M | 5,478 | $2 | 265,005 | Form 4 |
| 2026-07-14 | Oncology Institute, Inc. | S | 5,478 | $6.35 | 259,527 | Form 4 |
| 2026-07-14 | Oncology Institute, Inc. | S | 17,974 | $6.43 | 259,527 | Form 4 |
| 2026-07-14 | Oncology Institute, Inc. | M | 17,974 | $1.87 | 277,501 | Form 4 |
Questions
What stock did Podnos Yale buy or sell?
Podnos Yale reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($150K), across 1 company.
Is Podnos Yale the same person as other filers with this name?
This page covers SEC CIK 1891104 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/podnos-yale-1891104.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.